Table 1 Outcomes reported and duration of follow-up time period
Study | Outcomes reported in the original studies | Duration of follow-up time period (months) |
|---|---|---|
Iglesias2019 [17] | All-cause mortality, cardiac death, MI, repeated revascularization, TLR, TVR, cerebrovascular events, TIA, stroke, ischemic stroke, intra-cerebral hemorrhagic stroke, TLF, TVF, MACEs, definite ST, definite or probable ST | 60 months |
Lee2017 [18] | TLF | 24 months |
Lenz2021 [19] | MACEs, all-cause mortality, cardiac death, MI, TLR, definite ST, probable ST, definite/probable ST | 120 months |
Li2012 [20] | All-cause mortality, cardiac death, MI, TLR, MACEs, repeated revascularization | 48 months |
Rola2021 [21] | MACEs, all-cause mortality, cardiac death, MI, ST, repeated revascularization, TVR, TLR | 12 months |
Tang2018 [22] | MACEs, all-cause mortality, cardiac death, MI, ST, repeated revascularization, TVR, TLR, stroke | 24 months |
Wiermer2017 [23] | Cardiac death, all-cause mortality, MI, TLR, TVR, MACEs, TLF, definite and probable ST | 60 months |